Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. | 215,000 | reported | 15 Oct 2025 | tx 3+1,312,279 |
| Odyssey Group International, Inc. | 37,500 | reported | 16 Jan 2024 | tx 4+837,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Oct 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 215,000 | 0.00 USD | deriv |
| 16 May 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 750,000 | 0.00 USD | |
| 16 May 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 347,279 | 0.00 USD | deriv |
| 16 Jan 2024 | GRANT_AWARD | Odyssey Group International, Inc. | 37,500 | 0.09 USD | deriv |
| 29 Dec 2023 | GRANT_AWARD | Odyssey Group International, Inc. | 200,000 | 0.10 USD | deriv |
| 01 Nov 2022 | GRANT_AWARD | Odyssey Group International, Inc. | 125,000 | 0.25 USD | deriv |
| 01 Nov 2022 | GRANT_AWARD | Odyssey Group International, Inc. | 475,000 | 0.25 USD | deriv |